Pharmaceutical activity in Digital Health
Globally, 1,008 Pharmaceutical companies have joined up with Digital Health ventures in partnerships. In the last year, 352 collaborations between pharmaceutical firms and Digital Health ventures were revealed, marking an 15.1% decrease compared to the prior year's 299 disclosed partnerships.
Over the past 5 years, 1865 partnerships were announced between pharmaceutical companies and Digital Health ventures. North America leads in partnerships, representing 47.1% of all pharmaceutical collaborations in this timeframe.
AstraZeneca emerges as the most active pharmaceutical entity, announcing 209 partnerships with Digital Health ventures. Their latest collaboration with FamiOne (ファミワン) was disclosed in May 2026.
Most recently, on June 11th, 2026, Ildong Pharmaceutical announced its partnership with WELT (웰트). This collaboration marks WELT (웰트)'s 2nd partnership with a pharmaceutical company.
Over the past 5 years, 1865 partnerships were announced between pharmaceutical companies and Digital Health ventures. North America leads in partnerships, representing 47.1% of all pharmaceutical collaborations in this timeframe.
AstraZeneca emerges as the most active pharmaceutical entity, announcing 209 partnerships with Digital Health ventures. Their latest collaboration with FamiOne (ファミワン) was disclosed in May 2026.
Most recently, on June 11th, 2026, Ildong Pharmaceutical announced its partnership with WELT (웰트). This collaboration marks WELT (웰트)'s 2nd partnership with a pharmaceutical company.
Last Updated: June 13, 2026
Corporates
Result: 1008